Nath Bio-Genes (India) Ltd

📊 Nath Bio-Genes Q3 & 9M Results Meeting Scheduled for Jan 31, 2026

• Board meeting scheduled for January 31, 2026 to approve unaudited financial results

• Results cover Q3 and nine months ended December 31, 2025

• Includes both standalone and consolidated financial figures

• Trading window closed from December 31, 2025 to February 3, 2026